Climb Bio, Inc. (CLYM)

7.25 +0.07 (+0.97%) USD  |  NASDAQ  |  Mar 09, 16:00
7.30 +0.05 (+0.69%) After-Hours: 20:00
More

Climb Bio EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CLYM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Oramed Pharmaceuticals, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade
PepGen Inc. Upgrade